SHR-A1811, a novel anti-HER2 antibody–drug conjugate with optimal drug-to-antibody ratio, efficient tumor killing potency, and favorable safety profiles.
Saved in:
| Title: | SHR-A1811, a novel anti-HER2 antibody–drug conjugate with optimal drug-to-antibody ratio, efficient tumor killing potency, and favorable safety profiles. |
|---|---|
| Authors: | Zhang, Ting1 (AUTHOR), Xu, Jianyan1 (AUTHOR), Yin, Junzhao1 (AUTHOR), Gao, Yun1 (AUTHOR), Zheng, Hanwen1 (AUTHOR), Fu, Beibei1 (AUTHOR), Sun, Jiakang1 (AUTHOR), Xu, Zhibin1 (AUTHOR), Tu, Shiwei1 (AUTHOR), Mao, Yuchang1 (AUTHOR), Wen, Weiyun1 (AUTHOR), Qu, Bolei1 (AUTHOR), You, Lingfeng1 (AUTHOR), Xue, Zhendong1 (AUTHOR), Sun, Xing2 (AUTHOR), Cao, Dan1 (AUTHOR), Feng, Jun1 (AUTHOR), Hu, Min1 (AUTHOR) min.hu@hengrui.com, He, Feng1 (AUTHOR) feng.he@hengrui.com |
| Source: | PLoS ONE. 6/26/2025, Vol. 20 Issue 6, p1-16. 16p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 186210175 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: SHR-A1811, a novel anti-HER2 antibody–drug conjugate with optimal drug-to-antibody ratio, efficient tumor killing potency, and favorable safety profiles. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Zhang%2C+Ting%22">Zhang, Ting</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xu%2C+Jianyan%22">Xu, Jianyan</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yin%2C+Junzhao%22">Yin, Junzhao</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gao%2C+Yun%22">Gao, Yun</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zheng%2C+Hanwen%22">Zheng, Hanwen</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fu%2C+Beibei%22">Fu, Beibei</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sun%2C+Jiakang%22">Sun, Jiakang</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xu%2C+Zhibin%22">Xu, Zhibin</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tu%2C+Shiwei%22">Tu, Shiwei</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mao%2C+Yuchang%22">Mao, Yuchang</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wen%2C+Weiyun%22">Wen, Weiyun</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Qu%2C+Bolei%22">Qu, Bolei</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22You%2C+Lingfeng%22">You, Lingfeng</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xue%2C+Zhendong%22">Xue, Zhendong</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sun%2C+Xing%22">Sun, Xing</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cao%2C+Dan%22">Cao, Dan</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Feng%2C+Jun%22">Feng, Jun</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hu%2C+Min%22">Hu, Min</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> min.hu@hengrui.com</i><br /><searchLink fieldCode="AR" term="%22He%2C+Feng%22">He, Feng</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> feng.he@hengrui.com</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22PLoS+ONE%22">PLoS ONE</searchLink>. 6/26/2025, Vol. 20 Issue 6, p1-16. 16p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=186210175 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1371/journal.pone.0326691 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 16 StartPage: 1 Titles: – TitleFull: SHR-A1811, a novel anti-HER2 antibody–drug conjugate with optimal drug-to-antibody ratio, efficient tumor killing potency, and favorable safety profiles. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zhang, Ting – PersonEntity: Name: NameFull: Xu, Jianyan – PersonEntity: Name: NameFull: Yin, Junzhao – PersonEntity: Name: NameFull: Gao, Yun – PersonEntity: Name: NameFull: Zheng, Hanwen – PersonEntity: Name: NameFull: Fu, Beibei – PersonEntity: Name: NameFull: Sun, Jiakang – PersonEntity: Name: NameFull: Xu, Zhibin – PersonEntity: Name: NameFull: Tu, Shiwei – PersonEntity: Name: NameFull: Mao, Yuchang – PersonEntity: Name: NameFull: Wen, Weiyun – PersonEntity: Name: NameFull: Qu, Bolei – PersonEntity: Name: NameFull: You, Lingfeng – PersonEntity: Name: NameFull: Xue, Zhendong – PersonEntity: Name: NameFull: Sun, Xing – PersonEntity: Name: NameFull: Cao, Dan – PersonEntity: Name: NameFull: Feng, Jun – PersonEntity: Name: NameFull: Hu, Min – PersonEntity: Name: NameFull: He, Feng IsPartOfRelationships: – BibEntity: Dates: – D: 26 M: 06 Text: 6/26/2025 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 19326203 Numbering: – Type: volume Value: 20 – Type: issue Value: 6 Titles: – TitleFull: PLoS ONE Type: main |
| ResultId | 1 |
